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ABSTRACT
It is well-known that many isoforms of toll-like receptors (TLRs) function as Th1 adjuvant receptors. Thus, the
ligands induce Th1 differentiation in an antigen non-specific manner. During the past few years, not only Th1,
but also Th2 adjuvants have been reported. Allergy-inducing materials, such as parasites, first stimulate den-
dritic cells (DCs) to change their character as professional antigen-presenting cells. Such a DC population
(DC2) can stimulate naive CD4T cells to induce differentiation into Th2. In some instances, DCs that can stimu-
late regulatory T cells are also induced. Interestingly, many of such substances are glycolipids or phospholipids
that mammalian species do not usually carry. In this paper, we show a cellular and molecular basis for Th2 ad-
juvants.
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INTRODUCTION
Recent progress in dendritic cell (DC) research re-
vealed that DCs with a specific character play pivotal
roles in inducing Th2 responses. Moreover, allergy-
inducing substances, carry not only protein allergen
but also other biological activities that relate to al-
lergy. Most of these activities are carried by small
molecules with adjuvant properties. DCs are usually
located in the interface between such environment
and the human body. In this sense, DCs play distinct
roles, compared with T cells and B cells. Thus, adju-
vant activities affect DCs to exert allergen non-
specific induction of allergic responses.
TH1 ADJUVANTS
Toll-like receptor (TLR) molecules expressed on DCs
function as adjuvant receptors.1 Environmental mole-
cules, such as certain nucleic acids,2,3 lipopolysaccha-
rides (LPS),4 and fungus-derived glycoprotein mole-
cules,5 alter DC function, by binding with a certain
isoform of TLR , and they usually induce Th1 re-
sponses. Because such DCs induce Th1 responses,
they are designated DC1, and such environmental
molecules are called Th1 adjuvants (Fig. 1).
TH2 ADJUVANTS
DC2 and Th2 adjuvants have been recently reported.
Th2 adjuvants induce Th2 responses in an antigen
non-specific manner, through the induction of DC2.
In other words, DCs that stimulate Th2 differentiation
are called DC2. Whelan et al. reported in 2000 the
Th2 adjuvant ES-62.6 ES-62 is a phosphorylcholine-
containing glycoprotein derived from nematode of fi-
laria. Bone marrow-derived immature DCs were first
incubated with GM-CSF and ES-62 for 24 hours, fol-
lowed by co-incubation with naive CD4T cells of
DO11.10-Tg mice, in the presence of OVA peptide.
Activated T cells were then re-stimulated with PMA +
ionomycin, and their cytokine production levels were
determined. Indeed, ES-62 apparently increased the
IL-4IFN-γ ratio, without affecting CD8086 balance.
van der Kleij et al. reported in 2002 that
schistosoma-derived phosphatidylserine directly
stimulates DCs and leads to Th2 induction (Fig. 2).
Interestingly, neither synthetic nor mammalian phos-
phatidylserine has such an activity . Schistosoma-
derived phosphatidylserine supposedly exhibits such
an activity through a unique structure in its acyl
base.7 In other words, parasites carry “allergens”, be-
cause they also carry Th2 adjuvant activity in an anti-
gen non-specific manner.
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Fig. 1 Th1 adjuvant. DCs stimulated with pathogen-associated molecular 
paterns (PAMPs) derived from microbes induce diferentiation of naive T 
cels into Th1 cels. TLR3, TLR7, TLR8 and TLR9 exist in the endosomes, 
while the other TLR isoforms are expressed on the plasma membrane.
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Fig. 2 Th2 adjuvant. DCs stimulated with phospholipids derived from hel-
minth induce diferentiation of naive T cels into Th2 cels.
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Schistosomas do not synthesize fatty acids de novo.
They modify the structure of host-derived fatty acids,
by using their own enzymes to elongate the acyl
base , thus allowing the appearance of parasite-
specific fatty acids, in the host-parasite interface. In-
terestingly, unsaturated lysophosphatidylserine (lyso-
PS) with a single acyl base, tends to modify DC func-
tion to induce IL-10-producing regulatory T cells (Tr).
This is partially blocked by a neutralizing antibody to
TLR2. On the other hand, Th2-inducing phosphatidyl-
serine with two acyl bases does not appear to use
TLR2 (Fig . 3). 8,9 Lysophosphatidic acid (Lyso-PA)
and sphingosine-1-phosphate (S1P) also induce DC2,
whereas lysophosphatidylcholine (Lyso-PC) induces
DC1. Because they are structurally similar in their
acyl bases, head groups might be important in deter-
mining their activity (Fig. 4).
It is yet to be determined as to what molecules on
DCs regulate T-cell differentiation. CCL2 or mono-
cyte chemoattractant protein-1 (MCP-1) are produced
by DCs. Gu et al. reported that in CCL2-- mice, de-
creased levels of Th2 and IgG1 responses to TNP-
OVA are observed. Indeed, they become resistant to
leishmania infection.10 However, CCL2 activity in hu-
mans has not yet been delineated. Certain immunity-
related molecules such as thymic stromal lym-
phopoietin (TSLP) are differentially expressed be-
tween humans and mice, raising the possibility that
rules in mice do not apply to humans.
Prostaglandins (PG), especially, PGE2 and PGD2
have been reported to carry Th2 adjuvant activity. In
this concern, Kalinski et al. reported that immature
DCs produce IL-12p40, when stimulated with TNF-α
and PGE2. Indeed, monomeric or homodimeric p40
act as antagonists for IL-12p70, allowing PGE2 to
function as a Th2 adjuvant. However, this is not the
only one mechanism by which PGE2 functions as a
Th2 adjuvant. Other mechanisms include: 1) PGE2
acts directly on T cells and suppress IFN-γ produc-
tion; 2) PGE2 inhibits IL-12R expression; and 3) PGE
2 stimulates monocytes to produce IL-10.11 Another
topic in this concern is a recent observation that pol-
len carries molecules cross-reactive with human PGE
2 or leukotriens.12
Other Th2 adjuvants include molecules expressed
by C. albicans, histamine, G protein-R, PRR glycolip-
ids , OX 40 L , Jagged 1, and Pam 3 Cys-Ser-Lys 4
( Pam 3 Cys ) . Pam 3 Cys is an active moiety of
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Fig. 3 Structure of Lyso-PS and phosphatidylserine which induce regulatory T cels and 
Th2 cels respectively.
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Fig. 4 Structural diferences in Lyso-PC, S1P, and Lyso-PC.
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mycoplasma-associated lipopeptide 2, and leads to
the activation of Erk and the stabilization of c-Fos.9,13
Then, is it necessary for Th2 adjuvants to reach
secondary lymphatic organs, to exhibit their biologi-
cal activity? In this concern, Coker et al. reported that
a genealogical tree can be drawn by using VH hyper-
mutation obtained from the nasal mucosa of allergic
rhinitis patients. These mutations include very similar
VDJ families of IgE and IgA classes, which are highly
indicative of local somatic hypermutation . Further-
Th2 Adjuvants
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Fig. 5 Preparation of naive CD4 T cels by magnetic separation.
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Fig. 6 Overview of the assay protocol for determination of the adjuvant activity.
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more, activation-induced cytidine deaminase (AID)
activity was increased in situ. None of these observa-
tions apply for allergic patients without rhinitis, indi-
cating that even the periphery is a place for somatic
hypermutation and class switching.14
With regard to local reactivities, Soumelis et al. re-
ported an interesting phenomenon.15 TSLP is an IL-7-
like cytokine. Murine TSLP plays a pivotal role in pri-
mary TB differentiation, but not in DCs . On the
other hand , in humans , TSLP activates CD 11 c-
positive DCs but has no effect on TB differentiation,
because TSLP receptor molecules are expressed on
DCs but not on TB cells in humans. They stimulated
DCs with TSLP, LPS and CD40L for 24 hours, fol-
lowed by the induction of alloreactive T cell re-
sponses using naive CD4 T cells. Six days after pri-
mary stimulation, T cells were re-stimulated with anti-
CD3 + anti-CD28, followed by the determination of
cytokine levels produced by T cells . Interestingly ,
TSLP-stimulated DCs produced TARC and MDC, and
induced T-cell differentiation towards Th2 type.
TSLP molecules are expressed solely on mast cells
in bone marrow-derived cells , and in other tissues
such as lung fibroblasts , bronchial smooth muscle
cells, skin keratinocytes, etc. Indeed, in atopic derma-
titis patients, DC-LAMP-positive DCs are co-localized
with TSLP-positive keratinocytes. It may be that envi-
ronmental substances stimulate the skin to produce
Matsushita S et al.
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Fig. 7 Stimulation of HLA-DQ induces the diferentiation of 
DC into DC2. HLA-DQ-mediated signals are transmited, as 
described below. 1. Anti-HLA-DQ Ab. 2. Biotinylated anti-
HLA-DQ Ab plus avidin. 3. Plate-bound anti-HLA-DQ Ab. 4. 
Agarose-conjugated anti-HLA-DQ Ab. 5. Emetine (de novo 
protein synthesis inhibitor) treated and HLA-DQ restricted T 
cels.
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Fig. 8 Restriction molecules and the diferentiation of 
Th1/2. HLA-DR-, DQ-, and DP-restricted T cels responsi-
ble for 19-mer peptide with random sequences (X19) were 
stimulated by 500 μM X19 with antigen-presenting cels. Af-
ter 48-hour incubation, culture supernatants were colected 
for measurements of IFN-γ and IL-4 production by ELISA. 
One spot indicates one cel line.
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TSLP, which activates DCs to produce Th2-attracting
chemokines. These DCs move towards lymph nodes
where they stimulate allergen-specific Th 2 cells ,
which in turn migrate back to the skin, based on the
concentration gradient of TARCMDC. All these ob-
servations indicate that keratinocytes play a key role
between the environment and DCs. It is conceivable
that mast cells and NKT cells also play a role between
the environment and DCs.
THE ASSAY SYSTEM FOR TH2 ADJUVANTS
We have been working under the hypothesis that
allergy-inducing substances such as food, endocrine
disruptors, mites, and pollen may also carry Th2 adju-
vant activity. Indeed, some of these substances were
shown to carry such an activity, through our studies.
Briefly, CD14-positive cells were isolated from human
PBMCs and incubated with IL-4 and GM-CSF for 6
days. These cells (immature DCs) were re-stimulated
with TNF-α, in the presence of adjuvants to be tested.
Two days after the incubation with adjuvants, super-
natants were collected for the determination of IL-12p
40, MDC, TARC, CCL-2 and IL-10. Cellular compo-
nents were further co-cultured with HLA-DR-non-
shared allogeneic naive CD4T cells (Fig. 5) to induce
mixed lymphocyte reaction (MLR). This process al-
lows naive T cells to differentiate into Th 1Th2.
Seven to nine days later, differentiated T cells were
re-stimulated with agonistic anti-CD3 and anti-CD28
antibodies, to be subjected to supernatant collection
for the determination of IL-4IFN-γ (Fig. 6).
ANTIGEN-PRESENTING MOLECULES AND
ADJUVANT ACTIVITY
We have been working with signal transduction
mechanisms through HLA molecules, and reported
that class II isoforms (DR, DQ and DP) transmit dis-
tinct signals into antigen-presenting cells (APCs ) .
When HLA-DQ and DP are used for antigen presenta-
tion, crosslinking of HLA-DQ and DP induced anti-
inflammatory monokine production from mono-
cytes.16 To further address these issues using DCs,
we stimulated DCs with anti-HLA-DQ mAb , and
found that signaling through HLA-DQ can induce dif-
ferentiation of DC2 (Fig. 7). 17 We then established
short-term T-cell lines reactive to randomized 19-mer
peptide ( X 19 ) , determined restriction molecules
clone by clone, and tested how Th1Th2 shift pat-
terns are associated with restriction HLA molecules
(Fig . 8). Indeed , as expected , HLA-DQ- and DP-
restricted T cells tend to show a Th2-shifted pheno-
type as compared with DR-restricted ones. These ob-
servations confirmed our previous findings on HLA-
linked immune-suppression genes, 18 at cellular lev-
els.
NOTCH LIGANDS AND ADJUVANT ACTIVI-
TIES
Notch signaling pathways are highly conserved in or-
ganisms ranging from invertebrates to mammals and
involved in cell fate choice during development. This
signaling is caused by interactions between the
Notch receptors and the Notch ligands , Delta and
Jagged members.19 In mammals, four Notch recep-
tors (Notch 1-4 ) and five Notch ligands (Delta 1,
Th2 Adjuvants
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Delta3, Delta4, Jagged1, and Jagged2) have been
identified. Notch signaling has been shown to play a
critical role in several steps of lymphoid cell commit-
ment and lineage decision.20
Recently , Amsen et al. have presented evidence
that different Notch ligands induced by Th1Th2 ad-
juvant activities on APCs instruct mature T cell differ-
entiation in mice.21 In their in vitro study, LPS known
as a strong Th1 adjuvant induced Delta4 and Jagged1
expression on DCs. MyD88-dependent TLR4 signal-
ing was required for the induction of Delta4 expres-
sion, while the Jagged1 expression was up-regulated
through MyD88-independent TLR4 signaling . LPS
can promote not only Th1 but also Th2 responses un-
der some conditions . 22 Th1 responses induced by
LPS depend on MyD 88, whereas a MyD 88-
independent pathway promotes Th 2 responses . 23
Thus, Jagged1 expression correlates with the ability
of LPS to promote Th2 responses, while Delta4 ex-
pression correlates with the ability of LPS to promote
Th1 responses. On the other hand, Th2 adjuvants,
PGE2 and cholera toxin induced Jagged2 expression,
whereas expression of Jagged1 and all Delta mem-
bers was barely affected . 21 APC retrovirally trans-
duced to express Jagged1 promoted Th2 differentia-
tion , while APC retrovirally transduced to express
Delta1 caused Th1 polarization and reduced Th2 re-
sponses.21 Based on these observations, Amsen et al.
concluded that the Jagged expression induced by
Th2 adjuvants on APCs contributes to Th2 polariza-
tion while the Delta expression induced by Th1 adju-
vants on APCs contributes to Th1 polarization. Con-
sistent with their conclusion , Maekawa et al. have
demonstrated induction of mouse Th1 differentiation
by Delta1-Notch3 interactions partly independent of
IL-12 signaling in vitro.24
However, more recently, de La Coste et al. have
presented a possibility that Delta4 may play a role in
induction of Th2 but not Th1 responses, reconstitut-
ing the immune system of lethally irradiated athymic
nunu mice with fetal liver cells retrovirally trans-
duced to overexpress Delta1 or Delta4.25 In addition,
several studies suggest that Jagged 1 induces Ag-
specific Tr differentiation instead of Th2 differentia-
tion.26-28
Collectively, Notch ligands expressed on APCs po-
tentially impact Th1Th2Tr differentiation, but the
nature of such effects still remains obscure. Most of
the previous studies have been based on mouse ex-
periments. To assess whether and how Th1Th2 ad-
juvant activities affect Notch ligand expression on hu-
man APCs, our efforts are underway using several
types of APC, such as monocyte-derived DCs and
several cell lines of monocytic or DC-like lineage. In
the preliminary experiments, Th1Th2 adjuvants in-
deed altered Notch ligand expression profiles on hu-
man APCs, although the patterns were partly differ-
ent from those previously observed in mice.21 In addi-
tion, the alteration in Notch ligand expression varied
to some degree among different types of APC (un-
published data).
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